Keywords
Pharmacological intervention
Viral clearance
Cervical lesions
Immune modulation
Submitted : 2024-10-26
Accepted : 2024-11-10
Published : 2024-11-25
Abstract
This study aims to evaluate the clinical effectiveness of different drug treatment regimens for cervical high-risk human papillomavirus (HR-HPV) infection. Through literature review and randomized group experiment design, the study compares the HPV-DNA clearance rate, TCT results, and colposcopic biopsy findings among the control group, interferon group, and combination treatment group after six months of treatment. The results indicate that recombinant human interferon-2b vaginal effervescent tablets can effectively improve HPV clearance and reduce the risk of lesion progression, although individual responses to treatment vary. Combination therapy may enhance treatment efficacy by boosting immune response. The study also explores the relationship between drug treatment, viral load, cervical lesions, and vaginal microecology, providing scientific support for clinical medication decisions and offering a detailed analysis of the role of pharmacological intervention in the prognosis of HR-HPV infections.
References
Shan W, Zhang T, Zhang TJ, et al., 2017, Epidemiological Status of HPV Infection in Chinese Women. Chinese Journal of Disease Control, 21(1): 89–93.
Yang Z, Li Y J, Cao L, et al., 2021, Treatment Strategy and Outcome of High-Grade Cervical Intraepithelial Lesion Patients. Chinese Journal of Clinical Gynecology and Obstetrics, 22(4): 356–359.
Baimuriyemu A, Zhang Y, Pan J, 2023, Advances in Clinical Treatment of High-Risk HPV Infection with Cervical Intraepithelial Lesions. Women and Children’s Health Guide, 2(23): 14–17.
Ouyang JH, Yuan CY, Yang MP, 2023, Correlation of HLA-E, HLA-G, and P16 Protein with High-Risk HPV Infection in Cervical Cancer Patients. Journal of Clinical and Experimental Medicine, 22(23): 2543–2547.
Li YM, Zhang YZ, Li XL, et al., 2023, Correlation Analysis of High-Risk HPV Infection and Cervical Lesions in HIV-Positive Women. Beijing Medical Journal, 45(12): 1019–1022.
Peng JY, Xu X, Li HL, 2023, Study on the Correlation Between Outcome of High-Risk HPV Infection and Vaginal Microecology. Marriage and Health, 29(22): 22–24.
Su YY, Yang H, 2023, Clinical Effect of Focused Ultrasound Treatment on Patients with Persistent High-Risk HPV Infection. Practical Electronic Journal of Gynecological Endocrinology, 10(33): 19–21.
Li B, 2023, Analysis of Vaginal Microbiological Test Results in Patients with Different Types of HPV Infection. Clinical Medicine, 43(11): 86–88.
Chen HC, Xie PL, Fang BX, et al., 2023, Analysis of the Relationship Between High-Risk HPV Infection and Genitourinary Mycoplasma Infection. Laboratory Medicine and Clinics, 20(24): 3589–3593.
Ma YQ, 2023, Influence of Awareness of High-Risk HPV Infection on Cervical Cancer Risk and HPV Vaccination. Practical Electronic Journal of Gynecological Endocrinology, 10(32): 37–39.